Authored By: Sarah
12 Sep 2023

Intravenous IV Solutions Market  Analysis | Asia to Dominate Market Growth through 2023-2027

Intravenous (IV) Solutions Market is estimated to grow at a CAGR of 7.11% between 2022 and 2027 followed by a revenue growth of USD 4,011.34 Mn. The prevalence of chronic diseases, the growing geriatric population, and the increasing demand for parenteral nutrition are propelling the market growth of the Intravenous (IV) Solutions Market across the world

This intravenous solutions Market can be segmented by type (partial parenteral nutrition and total parenteral nutrition), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and geography (Asia, North America, Europe, and Rest of World (ROW)).

Technavio has been monitoring the growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking. 

intravenous solutions market analysis, intravenous solutions market trends, intravenous solutions market trend analysis, intravenous solutions market share

Asia to Lead the market growth of Intravenous (IV) Solutions Market with 33% contribution

Asia to Lead the market growth of Intravenous (IV) Solutions Market

Asia is estimated to contribute 33% to the growth of the global intravenous IV solutions market during the forecast period with Japan, China, Singapore, India, and South Korea being the largest contributors in terms of revenue.

The primary growth drivers of the market comprise rising healthcare costs, the rising prevalence of chronic diseases, and an aging population followed by increasing disposable income, the introduction of infusion therapy devices, and the increasing number of clinics and hospitals. 

Technavio's report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. 

Core Companies of the Intravenous IV Solutions Market

When it comes to the leading market players some of the major names include Axa Parenterals Ltd., Baxter International Inc., Fresenius SE and Co. KGaA, Grifols SA, ICU Medical Inc., JW Pharmaceutical Corp., Lxir Medilabs Pvt. Ltd., MITS Healthcare Pvt. Ltd., Pfizer Inc., Salius Pharma Pvt. Ltd., Schwitz Biotech, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations and Research Pvt. Ltd., etc. Get a comprehensive report summary describing the market landscape in our data-backed report that captures the growth trajectory of the market with a wider understanding of the business ecosystem.

Intravenous IV Solutions Market: Key Highlights of the Report for 2023-2027

  • CAGR of the market during the forecast period 2023-2027
  • Detailed information on factors that will drive Intravenous IV Solutions Market growth during the next five years
  • Precise estimation of the Intravenous IV Solutions Market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the intravenous IV solutions industry across APAC, Europe, MEA, North America, and South America
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of Intravenous IV Solutions Market players.
Read News Read Less
Interested in this report?
Get your sample now!